Initial results of a multicenter phase 2 study of venetoclax in combination with R‐CHOP (VR‐CHOP) for patients with Richter SyndromeMatthew S. Davids, Philip A. Thompson, Yi Ren et al.|Hematological Oncology|2023Cited by 23
73 | PRIMARY ENDPOINT EVALUATION OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH R‐CHOP (VR‐CHOP) FOR PATIENTS WITH RICHTER SYNDROMEMatthew S. Davids, Kathleen A. Rogers, Christine E. Ryan et al.|Hematological Oncology|2025Cited by 0